3. Gemcitabine, taken intravenously, blows holes through the shield allowing T-cells to attack the tumour
2. A shield of protective cells, a characteristic of pancreatic cancer, prevents the immune response seeing the tumour
Innate
T-cells
Adaptive
T-cells
1. IMM-101 powerfully stimulates early response innate T-cells as well as the more targeted adaptive T-cells
Tumour
Skin
Chemotherapy drug
Gemcitabine
IMM-101
injected into skin
Lymph
node
3.
Gemcitabine, taken intravenously, blows holes through the shield allowing the T-cells to attack the tumour
2.
A shield of protective cells, a characteristic of pancreatic cancer, prevents the immune response seeing the tumour
Innate T-cells
Adaptive
T-cells
1.
IMM-101 powerfully stimulates early response innate T-cells as well as the more targeted adaptive T-cells
Tumour
Skin
Chemotherapy drug Gemcitabine
IMM-101 injected into skin
Lymph node